• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型梗阻性心肌病化学消融相关并发症危险因素的回顾性分析。

Retrospective Analysis of Risk Factors for Related Complications of Chemical Ablation on Hypertrophic Obstructive Cardiomyopathy.

机构信息

Department of Cardiology - Liaoning Provincial Jin Qiu Hospital, Liaoning Province - China.

Department of Cardiology - Liaoning Provincial People's Hospital, Liaoning Province - China.

出版信息

Arq Bras Cardiol. 2019 Apr;112(4):432-438. doi: 10.5935/abc.20190060. Epub 2019 Apr 1.

DOI:10.5935/abc.20190060
PMID:30942295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6459438/
Abstract

BACKGROUND

The analysis of risk factors for predicting related complications has not been reported to date.

OBJECTIVE

This study aims to investigate the risk factors of related complications of percutaneous transluminal septal myocardial ablation (PTSMA) for hypertrophic obstructive cardiomyopathy (HOCM) retrospectively.

METHOD

Clinical data, and one-year follow-up results of patients with HOCM, who underwent PTSMA between January 2000 and July 2013 in the Department of Cardiology, Liaoning Province People's Hospital, Liaoning Province, China, were retrospectively analyzed to determine risk factors for operative complications with multiple logistic regression analysis. All p values are two-sided, with values of p < 0.05 being considered statistically significant.

RESULTS

Among 319 patients with HOCM, PTSMA was performed in 224 patients (120 males and 104 females, mean age was 48.20 ± 14.34 years old). The incidence of PTSMA procedure-related complications was 36.23% (66/224), which included three cardiac deaths, two cardiac shocks, one ST-segment elevated myocardial infarction, two ventricular fibrillations, 20 third-degree atrioventricular (AV) blocks (four patients were implanted with a permanent pacemaker (PPM)), 32 complete right bundle branch blocks, two complete left bundle branch blocks, and four puncture-related complications. After multivariate logistic regression analysis, it was found that age, gender, coronary artery diseases, diabetes, heart rate, cardiac function on admission, the number of septal ablations, and the volume of alcohol were not independent risk factors correlated to the whole complications, except for hypertension (OR: 4.856; 95% CI: 1.732-13.609). Early experience appears to be associated with the occurrence of complications.

CONCLUSION

Hypertension was an independent risk factor for PTSMA procedure-related complications. It might be much safer and more efficient if PTSMA procedures are restricted to experienced centers, according to the analysis results for the learning curve.

摘要

背景

目前尚未有分析预测经皮腔内室间隔心肌消融术(PTSMA)相关并发症的危险因素的报道。

目的

本研究旨在回顾性分析辽宁省人民医院心内科 2000 年 1 月至 2013 年 7 月行 PTSMA 的肥厚型梗阻性心肌病(HOCM)患者的临床资料及 1 年随访结果,采用多因素 logistic 回归分析确定手术相关并发症的危险因素。所有 p 值均为双侧,p<0.05 为差异有统计学意义。

结果

319 例 HOCM 患者中,224 例行 PTSMA(男 120 例,女 104 例,平均年龄 48.20±14.34 岁)。PTSMA 相关并发症发生率为 36.23%(66/224),包括 3 例心脏性死亡、2 例心脏电复律、1 例 ST 段抬高型心肌梗死、2 例心室颤动、20 例三度房室传导阻滞(4 例植入永久性起搏器)、32 例完全性右束支阻滞、2 例完全性左束支阻滞、4 例穿刺相关并发症。多因素 logistic 回归分析显示,年龄、性别、冠状动脉疾病、糖尿病、心率、入院时心功能、室间隔消融次数及酒精用量均不是与全因并发症相关的独立危险因素,而高血压是(OR:4.856;95%CI:1.732~13.609)。早期经验似乎与并发症的发生有关。

结论

高血压是 PTSMA 相关并发症的独立危险因素。根据学习曲线的分析结果,PTSMA 手术如果仅限于有经验的中心进行,可能会更安全、更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c8/6459438/22a7a2017498/abc-112-04-0432-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c8/6459438/22a7a2017498/abc-112-04-0432-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c8/6459438/22a7a2017498/abc-112-04-0432-g01.jpg

相似文献

1
Retrospective Analysis of Risk Factors for Related Complications of Chemical Ablation on Hypertrophic Obstructive Cardiomyopathy.肥厚型梗阻性心肌病化学消融相关并发症危险因素的回顾性分析。
Arq Bras Cardiol. 2019 Apr;112(4):432-438. doi: 10.5935/abc.20190060. Epub 2019 Apr 1.
2
[Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].肥厚性梗阻性心肌病患者经皮腔内室间隔消融术后的长期预后
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Apr 24;48(4):294-301. doi: 10.3760/cma.j.cn112148-20190603-00312.
3
Real-world clinical outcomes of percutaneous transluminal septal myocardial ablation for patients with drug-refractory hypertrophic obstructive cardiomyopathy: results from a retrospective multicenter registry of non-high-volume centers.经皮腔内室间隔心肌消融术治疗药物难治性肥厚型梗阻性心肌病的真实世界临床结局:来自非高容量中心回顾性多中心登记处的结果。
Heart Vessels. 2022 Nov;37(11):1937-1946. doi: 10.1007/s00380-022-02100-4. Epub 2022 May 31.
4
[Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].[经皮腔内室间隔心肌消融术治疗肥厚性梗阻性心肌病]
Zhonghua Nei Ke Za Zhi. 2006 Mar;45(3):210-2.
5
Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy.经皮腔内室间隔心肌消融术治疗药物难治性肥厚性梗阻性心肌病后,改善与心力衰竭状态相关的睡眠呼吸障碍严重程度。
Heart Vessels. 2017 Nov;32(11):1320-1326. doi: 10.1007/s00380-017-0997-0. Epub 2017 May 29.
6
Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center.经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病:来自单一中心119例患者的中国经验
Int J Cardiol. 2004 Feb;93(2-3):197-202. doi: 10.1016/j.ijcard.2003.03.005.
7
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病:25例患者的急性结果及3个月随访
J Am Coll Cardiol. 1998 Feb;31(2):252-8. doi: 10.1016/s0735-1097(97)00508-1.
8
Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病经皮腔内室间隔心肌消融术的并发症
Chin Med J (Engl). 2002 Sep;115(9):1283-6.
9
Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy.梗阻性肥厚型心肌病患者经皮腔内室间隔心肌消融术中的心腔内超声心动图引导
Int J Cardiovasc Intervent. 2005;7(3):134-7. doi: 10.1080/14628840500280575.
10
Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病经皮腔内室间隔心肌消融术后延迟出现的心电图改变
J Electrocardiol. 2007 Oct;40(4):356.e1-6. doi: 10.1016/j.jelectrocard.2006.12.003. Epub 2007 Feb 20.

引用本文的文献

1
Alcohol-induced right bundle branch block is associated with a benign outcome in HOCM after alcohol septum ablation (ASA).酒精性右束支传导阻滞与肥厚型梗阻性心肌病(HOCM)酒精间隔消融术(ASA)后的良性预后相关。
Clin Res Cardiol. 2022 Feb;111(2):175-185. doi: 10.1007/s00392-021-01847-6. Epub 2021 Mar 26.
2
Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM).梗阻性肥厚型心肌病(oHCM)的间隔消融术
Arq Bras Cardiol. 2019 Apr;112(4):439-440. doi: 10.5935/abc.20190066.

本文引用的文献

1
Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria.加拿大(2007-2011 年)基于空腹血糖和糖化血红蛋白筛查标准的糖尿病前期和未确诊糖尿病的流行率。
Diabetes Care. 2015 Jul;38(7):1299-305. doi: 10.2337/dc14-2474. Epub 2015 Apr 7.
2
Short and medium term outcomes of surgery for patients with hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病患者手术的短期和中期结果
Ann Thorac Surg. 2015 Apr;99(4):1213-9. doi: 10.1016/j.athoracsur.2014.11.020. Epub 2015 Feb 10.
3
Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy.
区分运动员的左心室肥厚与肥厚型心肌病患者的左心室肥厚。
Am J Cardiol. 2014 Nov 1;114(9):1383-9. doi: 10.1016/j.amjcard.2014.07.070. Epub 2014 Aug 12.
4
Surgical septal myectomy for hypertrophic cardiomyopathy in Greece: a single-center initial experience.希腊肥厚型心肌病的外科室间隔心肌切除术:单中心初步经验。
Hellenic J Cardiol. 2014 Mar-Apr;55(2):132-8.
5
Remote infarction following percutaneous transluminal septal myocardial ablation: a report of two cases.
Cardiovasc Interv Ther. 2011 May;26(2):142-6. doi: 10.1007/s12928-010-0038-8. Epub 2010 Nov 5.
6
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断和治疗指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告。与美国胸外科协会、美国超声心动图学会、美国核心脏病学会、美国心力衰竭学会、心律学会、心血管造影和介入学会以及胸外科医师学会合作制定。
J Am Coll Cardiol. 2011 Dec 13;58(25):e212-60. doi: 10.1016/j.jacc.2011.06.011. Epub 2011 Nov 8.
7
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断与治疗指南:执行摘要:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2011 Dec 13;124(24):2761-96. doi: 10.1161/CIR.0b013e318223e230. Epub 2011 Nov 8.
8
Contribution of genetic factors to the pathogenesis of dilated cardiomyopathy: the cause of dilated cardiomyopathy: genetic or acquired? (genetic-side).遗传因素对扩张型心肌病发病机制的影响:扩张型心肌病的病因:遗传或获得性?(遗传因素方面)
Circ J. 2011;75(7):1756-65; discussion 1765. doi: 10.1253/circj.cj-11-0368. Epub 2011 May 27.
9
[How to improve the safety of percutaneous transluminal septal myocardial ablation].
Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Mar;39(3):193-5.
10
Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病行间隔消融术后的生存和心源性猝死。
Scand Cardiovasc J. 2011 Jun;45(3):153-60. doi: 10.3109/14017431.2011.565793. Epub 2011 Mar 29.